Galunisertib enhances chimeric antigen receptor-modified T cell function
Submitted: 16 March 2020
Accepted: 11 April 2020
Published: 19 June 2020
Accepted: 11 April 2020
Abstract Views: 1076
PDF: 753
Supplementary: 0
HTML: 10
Supplementary: 0
HTML: 10
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.